Trial Profile
Obesity Protocol Targeting and Investigational Option for a New weight loss Solution.
Status:
Active, no longer recruiting
Phase of Trial:
Phase II
Latest Information Update: 16 Jul 2019
Price :
$35
*
At a glance
- Drugs LAT 8881 (Primary)
- Indications Obesity
- Focus Therapeutic Use
- Acronyms OPTIONS
- Sponsors Calzada
- 29 Aug 2011 New source identified and integrated (Australian New Zealand Clinical Trials Registry; ACTRN12605000067673).
- 12 Oct 2006 The expected completion date for this trial is now 1 Dec 2006.
- 12 Oct 2006 New trial record.